F.D.A. Actos Update

Posted on Saturday, September 17th, 2011 at 8:19 pm    

In June, the FDA published this FDA Drug Safety Communication related to the use of the drug Actos and Actos Combinations.  In the Communication, the FDA stated the following:

“The U.S. Food and Drug Administration (FDA) is informing the public that use of the diabetes medication Actos (pioglitazone) for more than one year may be associated with an increased risk of bladder cancer. Information about this risk will be added to the Warnings and Precautions section of the label for pioglitazone-containing medicines. The patient Medication Guide for these medicines will also be revised to include information on the risk of bladder cancer.”

The Wilson Law Office is currently investigating claims that involve a diagnosis of Bladder Cancer and the long term use of Actos, Actos Combinations or Pioglitazone.  Other drugs we are investigating are:  Actos, Actoplus Met, Actoplus Met XR, Duetact

*Never Stop Any Medication Before Talking To Your Doctor. 

If you or a loved one have taken any of these drugs and have been diagnosed with Bladder cancer, contact the Wilson Law Office for a Free Initial Consultation.

You can Call (662) 533-9111 anytime or the day or night and your call will be answered by an intake specialist.  You will be contacted by phone or letter after an attorney has reviewed your claim.